Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Engage Grants Program

Ryerson University

$25,000.00

Platform development for coupled ultrasound therapy and live cell imaging

FY 2015-16

Summary
Ultrasound-microbubble therapy is an emerging medical technology, useful for many diagnostic and therapeutic applications including the treatment of cancer and heart disease. Ultrasound-based therapies have many important advantages, including the portability and relatively low cost of typical ultrasound transducers, which will allow this technology to gain further widespread use. However, more information must be obtained by scientists about the effects of ultrasound-microbubble therapy on cells and tissues to allow the widespread commercialization of this therapy to new applications. Hence, there is a large demand and market from scientists as well as clinical diagnostics labs for instruments that allow examination of the biological effects of ultrasound microbubble on cells and tissues in real time. We seek support in the form of an NSERC Engage grant to collaborate with MD Precision Inc., an emerging leader in advanced ultrasound technologies to develop and test a prototype for a commercial instrument that couples ultrasound microbubble therapy and advanced microscopy. Successful completion of this project is a key step in the commercialization of this type of instrument, and will allow MD Precision Inc. to become a leader in this emerging technology market, resulting in the success for this Canadian company as well as the creation of high level research and manufacturing positions.
Program
Engage Grants Program
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
485852-2015
Name nom
Antonescu, Costin
Department département
Chemistry and Biology
Organization id
43
Institution établissement
Ryerson University
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2015
Competition year année de concours
2015
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1553
Committee name en
Ontario Internal Decision Committee
Committee name fr
Comité de décision interne pour l'Ontario
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
6400
Research subject group en
Life sciences research related to human health and disease
Research subject group fr
Sciences de la vie liées à la santé publique et aux maladies humaines
Research subject en
Life sciences research related to human health and disease
Research subject fr
Sciences de la vie liées à la santé publique et aux maladies humaines
Partie
1
Nb partie
1
Application title
Platform development for coupled ultrasound therapy and live cell imaging
Keyword
NSERC
Application summary
Ultrasound-microbubble therapy is an emerging medical technology, useful for many diagnostic and therapeutic applications including the treatment of cancer and heart disease. Ultrasound-based therapies have many important advantages, including the portability and relatively low cost of typical ultrasound transducers, which will allow this technology to gain further widespread use. However, more information must be obtained by scientists about the effects of ultrasound-microbubble therapy on cells and tissues to allow the widespread commercialization of this therapy to new applications. Hence, there is a large demand and market from scientists as well as clinical diagnostics labs for instruments that allow examination of the biological effects of ultrasound microbubble on cells and tissues in real time. We seek support in the form of an NSERC Engage grant to collaborate with MD Precision Inc., an emerging leader in advanced ultrasound technologies to develop and test a prototype for a commercial instrument that couples ultrasound microbubble therapy and advanced microscopy. Successful completion of this project is a key step in the commercialization of this type of instrument, and will allow MD Precision Inc. to become a leader in this emerging technology market, resulting in the success for this Canadian company as well as the creation of high level research and manufacturing positions.